首页 > 最新文献

Journal of gastroenterology and hepatology research最新文献

英文 中文
Differences In quality of life between patients with functional dyspepsia after esophagogastroduodenoscopy with empiric treatment and placebo 经验性治疗与安慰剂对食道胃十二指肠镜检查后功能性消化不良患者生活质量的影响
Pub Date : 2021-01-01 DOI: 10.53388/ghr2021-06-034
S. Sumardjo, N. Ratnasari, P. Bayupurnama
Functional dyspepsia is a common health problem found in society. Few of multifactorial aspects which become the underlying cause of functional dyspepsia are anxiety and psychosocial problem. Esophagogastroduodenoscopy (EGD) examination can display exact information to patient with functional dyspepsia and expected to increase patient’s quality of life. It is still necessary to evaluate the advantages of EGD examination in improving patient’s quality of life.A Randomized double blind controlled trial was conducted to compare between group of patients who have been given an empiric treatment(Proton pump inhibitor and prokinetic agents) and other who have been given a placebo for 2 weeks after underwent EGD examination in patients with functional dyspepsia. The primary outcome of this study is the decrease of NDI-SF score on both of groups at the end of study.A total of 42 patients (22 in EGD+placebo group [Group I] and 20 in EGD + treatment group[Group II]) were enrolled. NDI-SF score decreased significantly in both groups, Group I (26.23±8.43 vs 19.59±7.62, P=0.001) and Group II (27.32±7.57 vs 19.21±5.68, P=0.002), 15 days after underwent EGD examination. NDI-SF score improvement between two groups 15 days after EGD was not significantly different (P=0.814). This study showed improvement in quality of life of patients whom diagnosed with functional dyspepsia after EGD examination in both groups. This improvement was not significantly different between two groups and showed the placebo effect of EGD on functional dyspepsia patient.
功能性消化不良是社会上常见的健康问题。焦虑和社会心理问题是导致功能性消化不良的几个重要因素。食管胃十二指肠镜检查能准确显示功能性消化不良患者的信息,有望提高患者的生活质量。评价EGD检查在提高患者生活质量方面的优势仍有必要。我们进行了一项随机双盲对照试验,比较功能性消化不良患者在接受EGD检查后给予经验性治疗(质子泵抑制剂和促动力学药物)和另一组给予安慰剂2周的患者。本研究的主要结局是两组在研究结束时NDI-SF评分的下降。共纳入42例患者,其中EGD+安慰剂组[组I] 22例,EGD+治疗组[组II] 20例。EGD检查15 d后,两组患者NDI-SF评分均显著降低,ⅰ组(26.23±8.43 vs 19.59±7.62,P=0.001),ⅱ组(27.32±7.57 vs 19.21±5.68,P=0.002)。EGD后15 d两组NDI-SF评分改善无显著性差异(P=0.814)。本研究显示两组经EGD检查诊断为功能性消化不良的患者的生活质量均有改善。这一改善在两组间无显著差异,显示了EGD对功能性消化不良患者的安慰剂效应。
{"title":"Differences In quality of life between patients with functional dyspepsia after esophagogastroduodenoscopy with empiric treatment and placebo","authors":"S. Sumardjo, N. Ratnasari, P. Bayupurnama","doi":"10.53388/ghr2021-06-034","DOIUrl":"https://doi.org/10.53388/ghr2021-06-034","url":null,"abstract":"Functional dyspepsia is a common health problem found in society. Few of multifactorial aspects which become the underlying cause of functional dyspepsia are anxiety and psychosocial problem. Esophagogastroduodenoscopy (EGD) examination can display exact information to patient with functional dyspepsia and expected to increase patient’s quality of life. It is still necessary to evaluate the advantages of EGD examination in improving patient’s quality of life.A Randomized double blind controlled trial was conducted to compare between group of patients who have been given an empiric treatment(Proton pump inhibitor and prokinetic agents) and other who have been given a placebo for 2 weeks after underwent EGD examination in patients with functional dyspepsia. The primary outcome of this study is the decrease of NDI-SF score on both of groups at the end of study.A total of 42 patients (22 in EGD+placebo group [Group I] and 20 in EGD + treatment group[Group II]) were enrolled. NDI-SF score decreased significantly in both groups, Group I (26.23±8.43 vs 19.59±7.62, P=0.001) and Group II (27.32±7.57 vs 19.21±5.68, P=0.002), 15 days after underwent EGD examination. NDI-SF score improvement between two groups 15 days after EGD was not significantly different (P=0.814). This study showed improvement in quality of life of patients whom diagnosed with functional dyspepsia after EGD examination in both groups. This improvement was not significantly different between two groups and showed the placebo effect of EGD on functional dyspepsia patient.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"103 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80639777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Effective Mechanism of Fructus Aurantii Immaturus in the Treatment of Chronic Atrophic Gastritis Based on Network Pharmacology and Molecular Docking Technology 基于网络药理学和分子对接技术分析枳实治疗慢性萎缩性胃炎的作用机制
Pub Date : 2021-01-01 DOI: 10.53388/ghr2021-03-028
Jing-Nuan Wu, Yingbing Mei, Nierui Huang, Sisi Li
{"title":"Analysis of the Effective Mechanism of Fructus Aurantii Immaturus in the Treatment of Chronic Atrophic Gastritis Based on Network Pharmacology and Molecular Docking Technology","authors":"Jing-Nuan Wu, Yingbing Mei, Nierui Huang, Sisi Li","doi":"10.53388/ghr2021-03-028","DOIUrl":"https://doi.org/10.53388/ghr2021-03-028","url":null,"abstract":"","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"16 1-2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78252534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Explanatory Factors for Severe Acute Malnutrition in 6 - 59 months of age Patients Admitted in the Therapeutic Nutritional Unit of N’Djamena, Chad 乍得恩贾梅纳营养治疗中心收治的6 - 59个月患者严重急性营养不良的解释因素
Pub Date : 2021-01-01 DOI: 10.53388/ghr2021-06-033
Neguemadji Ngardig, Kankeu Tonpouwo, Maryan Gelle, Alla-hein Appolinaire, B. Boy, N. Hange, Manoj Kumar, Sana Irfan, Lemingar Dessinsa, M. Kezia
Introduction: Globally Severe acute malnutrition(SAM) affects more than 29 million children under the age of five. Demographic and Health Survey and Multiple Indicators in Chad (EDS-MICS) of 2014-2015 survey found an acute malnutrition level of 13% out of which 9% was moderate and 4% was severe. The Causes of SAMS are multifactorial, relating to multiple domains such as society, culture, environment, education, livelihoods, agriculture, water, hygiene, etc. Despite this established evidence, the evidence of parental knowledge is unknown. Objective: The objective of our study was to determine the explanatory factors of SAM and its level of knowledge, understanding by the parents. Materials and Methods: A prospective descriptive study was conducted in 238 children aged 6-59 months admitted to therapeutic nutritional unit Alerte Santé of Ndjamena from November 15 to December 30, 2017. Results: During the study, the male sex (58.8%), the age group of 12-17 months (26.9%) and 6-8 months (24.4%) were the most represented and are the majorities in the urban area (72.3%). We were able to identify the various explanatory factors among which the level of education of mothers (62.2%), exclusive breastfeeding (2.3%), the food taboo (81%) are not insignificant. Malnutrition would be decompensated by the breakdown of food access (59%) and digestive diseases (74.8%) and respiratory diseases (73.5%). We found that parents have poor knowledge of malnutrition (87%). Conclusion: A good understanding of these main factors of malnutrition by parents might help to effectively combat severe acute malnutrition.
导言:在全球范围内,严重急性营养不良(SAM)影响着超过2900万名五岁以下儿童。2014-2015年乍得人口与健康调查和多项指标调查(EDS-MICS)发现,急性营养不良水平为13%,其中9%为中度营养不良,4%为重度营养不良。SAMS的成因是多因素的,涉及社会、文化、环境、教育、生计、农业、水、卫生等多个领域。尽管有这些既定的证据,但父母知情的证据是未知的。目的:本研究的目的是确定儿童心理健康量表的解释因素及家长对心理健康量表的认识和理解程度。材料与方法:对2017年11月15日至12月30日在恩贾梅纳(Ndjamena)的Alerte sant营养治疗单位住院的238名6-59个月的儿童进行前瞻性描述性研究。结果:研究中以男性(58.8%)、12 ~ 17月龄(26.9%)和6 ~ 8月龄(24.4%)最具代表性,以城区居多(72.3%)。我们能够识别出母亲受教育程度(62.2%)、纯母乳喂养(2.3%)、食物禁忌(81%)等各种解释因素并非微不足道。营养不良会因无法获得食物(59%)、消化系统疾病(74.8%)和呼吸系统疾病(73.5%)而失代偿。我们发现,家长对营养不良的认识较差(87%)。结论:家长了解营养不良的主要影响因素,有助于有效防治严重急性营养不良。
{"title":"Explanatory Factors for Severe Acute Malnutrition in 6 - 59 months of age Patients Admitted in the Therapeutic Nutritional Unit of N’Djamena, Chad","authors":"Neguemadji Ngardig, Kankeu Tonpouwo, Maryan Gelle, Alla-hein Appolinaire, B. Boy, N. Hange, Manoj Kumar, Sana Irfan, Lemingar Dessinsa, M. Kezia","doi":"10.53388/ghr2021-06-033","DOIUrl":"https://doi.org/10.53388/ghr2021-06-033","url":null,"abstract":"Introduction: Globally Severe acute malnutrition(SAM) affects more than 29 million children under the age of five. Demographic and Health Survey and Multiple Indicators in Chad (EDS-MICS) of 2014-2015 survey found an acute malnutrition level of 13% out of which 9% was moderate and 4% was severe. The Causes of SAMS are multifactorial, relating to multiple domains such as society, culture, environment, education, livelihoods, agriculture, water, hygiene, etc. Despite this established evidence, the evidence of parental knowledge is unknown. Objective: The objective of our study was to determine the explanatory factors of SAM and its level of knowledge, understanding by the parents. Materials and Methods: A prospective descriptive study was conducted in 238 children aged 6-59 months admitted to therapeutic nutritional unit Alerte Santé of Ndjamena from November 15 to December 30, 2017. Results: During the study, the male sex (58.8%), the age group of 12-17 months (26.9%) and 6-8 months (24.4%) were the most represented and are the majorities in the urban area (72.3%). We were able to identify the various explanatory factors among which the level of education of mothers (62.2%), exclusive breastfeeding (2.3%), the food taboo (81%) are not insignificant. Malnutrition would be decompensated by the breakdown of food access (59%) and digestive diseases (74.8%) and respiratory diseases (73.5%). We found that parents have poor knowledge of malnutrition (87%). Conclusion: A good understanding of these main factors of malnutrition by parents might help to effectively combat severe acute malnutrition.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"118 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87947797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Focus on microvascular invasion in hepatocellular carcinoma: a pathological perspective 肝细胞癌微血管侵袭的病理观察
Pub Date : 2021-01-01 DOI: 10.53388/ghr2021-03-031
Han Wang, Wen-Ling Cong
{"title":"Focus on microvascular invasion in hepatocellular carcinoma: a pathological perspective","authors":"Han Wang, Wen-Ling Cong","doi":"10.53388/ghr2021-03-031","DOIUrl":"https://doi.org/10.53388/ghr2021-03-031","url":null,"abstract":"","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82733988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital Reconversion of the Gastrointestinal Endoscopy Service at The National Medical Center November 20 Issste During the Covid-19 Pandemic 新冠肺炎大流行期间,国家医疗中心胃肠内窥镜服务的医院改造11月20日发布
Pub Date : 2020-12-31 DOI: 10.24966/GHR-2566/100030
Teresa Gómez
{"title":"Hospital Reconversion of the Gastrointestinal Endoscopy Service at The National Medical Center November 20 Issste During the Covid-19 Pandemic","authors":"Teresa Gómez","doi":"10.24966/GHR-2566/100030","DOIUrl":"https://doi.org/10.24966/GHR-2566/100030","url":null,"abstract":"","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"75 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87838084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Liver’s Fate Amid COVID-19 Pandemic COVID-19大流行期间肝脏的命运
Pub Date : 2020-12-21 DOI: 10.17554/j.issn.2224-3992.2020.09.977
M. B. Bestari, S. Abdurachman
Corona-virus disease (COVID-19) affected medical services worldwide because of its pandemic nature; including patients with chronic liver disease (CLD). Generally, there are three situations in which CLD patients can be affected by the coronavirus. Patients who have pre-existing liver conditions, especially those that need constant follow-up, will be exposed during follow-up visits to the hospital and are more vulnerable to infection. Second, patients with COVID-19 who have liver function derangements and incidental findings of ongoing CLD, especially those with cirrhosis will have more severe courses of the disease and possible acute-on-chronic liver failure. Finally, patients who undergo treatment for CLD who are infected with COVID-19, where drug-drug interactions are possible (e.g. lopinavir-ritonavir) that may increase the concentration of the protease inhibitor DAA for Hepatitis C treatment. This review is aims to provide guidelines for managing patients with CLD amid the pandemic, and how we move forward after the lockdown.
冠状病毒病(新冠肺炎)因其大流行性质而影响了全球医疗服务;包括患有慢性肝病(CLD)的患者。一般来说,CLD患者会在三种情况下受到冠状病毒的影响。已有肝脏疾病的患者,尤其是那些需要持续随访的患者,在医院的随访中会暴露在外,更容易感染。第二,患有肝功能紊乱和持续CLD的新冠肺炎患者,尤其是肝硬化患者,将有更严重的病程和可能的急性-慢性肝衰竭。最后,对感染新冠肺炎的CLD患者进行治疗,其中可能存在药物相互作用(如洛匹那韦-利托那韦),这可能会增加蛋白酶抑制剂DAA的浓度,用于丙型肝炎治疗。这篇综述旨在为在疫情期间管理CLD患者提供指导方针,以及我们在封锁后如何前进。
{"title":"The Liver’s Fate Amid COVID-19 Pandemic","authors":"M. B. Bestari, S. Abdurachman","doi":"10.17554/j.issn.2224-3992.2020.09.977","DOIUrl":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.977","url":null,"abstract":"Corona-virus disease (COVID-19) affected medical services worldwide because of its pandemic nature; including patients with chronic liver disease (CLD). Generally, there are three situations in which CLD patients can be affected by the coronavirus. Patients who have pre-existing liver conditions, especially those that need constant follow-up, will be exposed during follow-up visits to the hospital and are more vulnerable to infection. Second, patients with COVID-19 who have liver function derangements and incidental findings of ongoing CLD, especially those with cirrhosis will have more severe courses of the disease and possible acute-on-chronic liver failure. Finally, patients who undergo treatment for CLD who are infected with COVID-19, where drug-drug interactions are possible (e.g. lopinavir-ritonavir) that may increase the concentration of the protease inhibitor DAA for Hepatitis C treatment. This review is aims to provide guidelines for managing patients with CLD amid the pandemic, and how we move forward after the lockdown.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"9 1","pages":"3367-3372"},"PeriodicalIF":0.0,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42425677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Effects of Nutrients on Stress and Aggression: Integrative Approaches to Behavioral and Emotional Modification 营养物质对应激和攻击的影响:行为和情绪调节的综合方法
Pub Date : 2020-12-21 DOI: 10.17554/j.issn.2224-3992.2020.09.975
Vimala Alagappan, Ripal Shah, Robert C. Meisner
As research on the interplay of nutrition and mental health evolves, “nutritional medicine” is attracting new enthusiasm from clinicians across a broad range of clinical subspecialties. In this review, we describe potential relevance of 6 nutrients in particular — Vitamin A, Vitamin C, Zinc, Magnesium, L-tryptophan, and Omega-3 fatty acids — on reducing or preventing the target symptoms of stress and aggression. Briefly: (1) Vitamin A may reduce the physical symptoms of stress, including inflammation, while (2) Vitamin C may reduce psychological distress and attenuate acute mammalian stress-response; stress may (3) increase the body’s demand for Mg and exacerbate Mg deficiency, while Mg deficiency itself may increase vulnerability under particular stressors; (4) Zinc deficiency appears to correlate with psychological adaptive potential; (5) Omega-3 fatty acids may mitigate aggression and anger for stressed mammalians. Tryptophan (6) depletion, finally, appears to correlate with increased aggression. Broadly speaking, as the literature evolves, there increasingly appears to be meaningful correlations between these nutrients and stress and aggression that justifies a call for further research.
随着营养与心理健康相互作用研究的发展,“营养医学”正吸引着临床医生在广泛的临床亚专业领域的新热情。在这篇综述中,我们特别描述了6种营养素——维生素A、维生素C、锌、镁、l -色氨酸和Omega-3脂肪酸——在减少或预防压力和攻击的目标症状方面的潜在相关性。简而言之:(1)维生素A可以减轻应激的生理症状,包括炎症,而(2)维生素C可以减轻心理困扰,减轻急性哺乳动物应激反应;应激可(3)增加机体对镁的需求,加重缺镁,而缺镁本身可增加特定应激源下的易感性;(4)锌缺乏与心理适应电位相关;(5) ω -3脂肪酸可以减轻应激哺乳动物的攻击性和愤怒情绪。最后,色氨酸(6)的消耗似乎与攻击性增加有关。总的来说,随着文献的发展,这些营养物质与压力和攻击性之间似乎越来越有意义的相关性,这证明了进一步研究的必要性。
{"title":"The Effects of Nutrients on Stress and Aggression: Integrative Approaches to Behavioral and Emotional Modification","authors":"Vimala Alagappan, Ripal Shah, Robert C. Meisner","doi":"10.17554/j.issn.2224-3992.2020.09.975","DOIUrl":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.975","url":null,"abstract":"As research on the interplay of nutrition and mental health evolves, “nutritional medicine” is attracting new enthusiasm from clinicians across a broad range of clinical subspecialties. In this review, we describe potential relevance of 6 nutrients in particular — Vitamin A, Vitamin C, Zinc, Magnesium, L-tryptophan, and Omega-3 fatty acids — on reducing or preventing the target symptoms of stress and aggression. Briefly: (1) Vitamin A may reduce the physical symptoms of stress, including inflammation, while (2) Vitamin C may reduce psychological distress and attenuate acute mammalian stress-response; stress may (3) increase the body’s demand for Mg and exacerbate Mg deficiency, while Mg deficiency itself may increase vulnerability under particular stressors; (4) Zinc deficiency appears to correlate with psychological adaptive potential; (5) Omega-3 fatty acids may mitigate aggression and anger for stressed mammalians. Tryptophan (6) depletion, finally, appears to correlate with increased aggression. Broadly speaking, as the literature evolves, there increasingly appears to be meaningful correlations between these nutrients and stress and aggression that justifies a call for further research.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44005271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
COVID-19 Outbreak and IBD Patient: A Challenge COVID-19疫情和IBD患者:一个挑战
Pub Date : 2020-12-21 DOI: 10.17554/j.issn.2224-3992.2020.09.981
M. Maher, Hazem M Rizk
The COVID-19 pandemic, caused by coronavirus 2 (SARS-CoV-2), has developed as a intense challenge for healthcare systems allover the world. COVID-19 can be associated with gastrointestinal (GI) inflammation as SARS-CoV-2 enters cells via its receptor the angiotensin-converting enzyme 2, which is expressed on GI cells. There was a great demand to clarify the impact of COVID-19 on patients with inflammatory bowel disease (IBD), particularly those on immunosuppressive medications.
由冠状病毒2(SARS-CoV-2)引起的新冠肺炎大流行已成为世界各地医疗系统面临的严峻挑战。新冠肺炎可能与胃肠道(GI)炎症有关,因为SARS-CoV-2通过其受体血管紧张素转化酶2进入细胞,该酶在胃肠道细胞上表达。人们迫切需要澄清新冠肺炎对炎症性肠病(IBD)患者的影响,尤其是对免疫抑制药物的影响。
{"title":"COVID-19 Outbreak and IBD Patient: A Challenge","authors":"M. Maher, Hazem M Rizk","doi":"10.17554/j.issn.2224-3992.2020.09.981","DOIUrl":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.981","url":null,"abstract":"The COVID-19 pandemic, caused by coronavirus 2 (SARS-CoV-2), has developed as a intense challenge for healthcare systems allover the world. COVID-19 can be associated with gastrointestinal (GI) inflammation as SARS-CoV-2 enters cells via its receptor the angiotensin-converting enzyme 2, which is expressed on GI cells. There was a great demand to clarify the impact of COVID-19 on patients with inflammatory bowel disease (IBD), particularly those on immunosuppressive medications.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"9 1","pages":"3354-3356"},"PeriodicalIF":0.0,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45953219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of PEG Tube Misplacement in the Transverse Colon: Method of Introducing a Gastrografin into the Stomach 预防横结肠内PEG管错位:胃内引入胃grafin的方法
Pub Date : 2020-10-21 DOI: 10.17554/j.issn.2224-3992.2020.09.968
H. Ono, H. Yokoyama, H. Yoshida, H. Fukushima, M. Kawakami, M. Okamura, T. Aoki, N. Asakage, K. Nagashima, Y. Danjo, H. Hayashi, H. Nishihara, Y. Shimizu, T. Shimamura, M. Kusano
AIM: A colocutaneous fistula is a rare late complication of percutaneous endoscopic gastrostomy (PEG) feeding placement that occurs as a result of the interposition of the colon between the anterior abdominal and gastric walls. In the current study, we sought to retrospectively study the method of introducing the water-soluble contrast agent into the stomach by using a nasogastric tube before PEG feeding placement, with the intention to develop a method to prevent PEG-related colocutaneous fistula. MATERIALS AND METHODS: Between October 2003 and April 2020, 341 patients underwent PEG placement at Seiwa Memorial Hospital. Patients were divided into two groups: 232 patients in Group A were given water-soluble contrast agent and 109 patients in Group B were not. All patients underwent PEG using introducer method placement after gastropexy under fluoroscopy. RESULTS: In Group A, 139 (59.9%) patients received PEG with a water-soluble contrast agent placed into the transverse colon, 75 (32.3%) received PEG with gas in the colon, and 7 (3.0%) patients received surgical gastrostomy. In Group B, 38 (34.8%) patients received PEG with gas in the colon, 60 (55.1%) patients received PEG with finger palpation and transillumination, and 10 (9.2%) patients received surgical gastrostomy. Colocutaneous fistula was not observed in either group, but there was a significant difference in the frequency of surgical gastrostomy between Group A and B ( p = 0.0148). CONCLUSION: The use of water-soluble contrast agent in the stomach was safe, reliable, and cost effective for PEG tube placement, and is recommended to decrease surgical gastrostomy.
目的:结肠皮瘘是经皮内镜胃造瘘术(PEG)置入术中一种罕见的晚期并发症,由于结肠插入腹前壁和胃壁之间而发生。在目前的研究中,我们试图回顾性研究在PEG喂养前使用鼻胃导管将水溶性造影剂引入胃中的方法,目的是开发一种预防PEG相关结肠皮瘘的方法。材料和方法:2003年10月至2020年4月,341名患者在Seiwa Memorial医院接受了PEG植入术。将患者分为两组:A组232例给予水溶性造影剂,B组109例不给予水溶型造影剂。所有患者在荧光镜下进行胃镜检查后,均采用导入器法放置PEG。结果:在A组中,139名(59.9%)患者接受了将水溶性造影剂放入横结肠的PEG治疗,75名(32.3%)接受了将气体放入结肠的PEG,7名(3.0%)患者接受外科胃造口术。在B组中,38名(34.8%)患者接受了结肠内气体PEG,60名(55.1%)患者接受手指触诊和透照PEG,10名(9.2%)患者接受胃造口术。两组均未发现结肠皮瘘,但a组和B组胃造口术的频率有显著差异(p=0.0148)。结论:在胃中使用水溶性造影剂放置PEG管是安全、可靠和经济有效的,建议减少胃造口术。
{"title":"Prevention of PEG Tube Misplacement in the Transverse Colon: Method of Introducing a Gastrografin into the Stomach","authors":"H. Ono, H. Yokoyama, H. Yoshida, H. Fukushima, M. Kawakami, M. Okamura, T. Aoki, N. Asakage, K. Nagashima, Y. Danjo, H. Hayashi, H. Nishihara, Y. Shimizu, T. Shimamura, M. Kusano","doi":"10.17554/j.issn.2224-3992.2020.09.968","DOIUrl":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.968","url":null,"abstract":"AIM: A colocutaneous fistula is a rare late complication of percutaneous endoscopic gastrostomy (PEG) feeding placement that occurs as a result of the interposition of the colon between the anterior abdominal and gastric walls. In the current study, we sought to retrospectively study the method of introducing the water-soluble contrast agent into the stomach by using a nasogastric tube before PEG feeding placement, with the intention to develop a method to prevent PEG-related colocutaneous fistula. MATERIALS AND METHODS: Between October 2003 and April 2020, 341 patients underwent PEG placement at Seiwa Memorial Hospital. Patients were divided into two groups: 232 patients in Group A were given water-soluble contrast agent and 109 patients in Group B were not. All patients underwent PEG using introducer method placement after gastropexy under fluoroscopy. RESULTS: In Group A, 139 (59.9%) patients received PEG with a water-soluble contrast agent placed into the transverse colon, 75 (32.3%) received PEG with gas in the colon, and 7 (3.0%) patients received surgical gastrostomy. In Group B, 38 (34.8%) patients received PEG with gas in the colon, 60 (55.1%) patients received PEG with finger palpation and transillumination, and 10 (9.2%) patients received surgical gastrostomy. Colocutaneous fistula was not observed in either group, but there was a significant difference in the frequency of surgical gastrostomy between Group A and B ( p = 0.0148). CONCLUSION: The use of water-soluble contrast agent in the stomach was safe, reliable, and cost effective for PEG tube placement, and is recommended to decrease surgical gastrostomy.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"9 1","pages":"3320-3324"},"PeriodicalIF":0.0,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47249627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thirty-Day Unplanned Readmission and Its Effect on 90-Day Mortality in Hepatocellular Carcinoma Patients Undergoing Partial Hepatectomy 肝部分切除术后30天非计划再切除及其对肝癌患者90天死亡率的影响
Pub Date : 2020-10-21 DOI: 10.17554/j.issn.2224-3992.2020.09.973
Yongyue Qi, T. LeVan, G. Haynatzki, C. Are, P. Farazi
Background : Despite advances of surgical techniques, hepatectomy continues to be potentially dangerous and is associated with postoperative mortality, morbidity and readmission. The objective of this study was to determine the effect of 30-day unplanned readmission on ‘conditional’ 90-day mortality among hepatocellular carcinoma (HCC) patients that underwent partial hepatectomy. Methods : National Cancer Database (NCDB) was queried from 2004 to 2012 for patients with hepatocellular carcinoma (HCC) who underwent partial hepatectomy. Thirty-day unplanned readmission rate, and associated risk factors, was determined for 7,696 patients. The association between 30-day unplanned readmission and conditional 90-day mortality was further addressed. Results : The 30-day unplanned readmission rate for patients with HCC that underwent partial hepatectomy was 5.2%. Risk factors associated with 30-day unplanned readmission were sex, race/ethnicity, Charlson-Deyo score, and annual hospital hepatectomy volume. An overall adjusted odds ratio of having conditional 90-day mortality was 2.325 times higher (95% CI 1.643 - 3.219) among patients with a history of 30-day unplanned readmission than those without. This association was dependent on age, sex, race/ethnicity, insurance status, alpha-fetoprotein (AFP), liver fibrosis, Charlson-Deyo comorbidity score and annual hospital hepatectomy volume. Conclusion : Efforts in patient care should be taken to reduce 30-day unplanned readmission after partial hepatectomy for patients with HCC to reduce conditional 90-day mortality.
背景:尽管手术技术不断进步,肝切除术仍然具有潜在的危险,并且与术后死亡率、发病率和再入院率相关。本研究的目的是确定30天计划外再入院对接受部分肝切除术的肝细胞癌(HCC)患者“条件性”90天死亡率的影响。方法:查询国家癌症数据库(NCDB) 2004 - 2012年行肝部分切除术的肝细胞癌(HCC)患者。7696例患者的30天非计划再入院率及相关危险因素被确定。30天非计划再入院与90天有条件死亡率之间的关系得到进一步探讨。结果:行部分肝切除术的HCC患者30天非计划再入院率为5.2%。与30天非计划再入院相关的危险因素有性别、种族/民族、Charlson-Deyo评分和每年住院肝切除量。有30天非计划再入院史的患者有条件90天死亡率的总体调整优势比是无计划再入院史患者的2.325倍(95% CI 1.643 - 3.219)。这种关联依赖于年龄、性别、种族/民族、保险状况、甲胎蛋白(AFP)、肝纤维化、Charlson-Deyo合病评分和每年住院肝切除术量。结论:应加强患者护理,减少HCC患者部分肝切除术后30天的意外再入院,以降低有条件的90天死亡率。
{"title":"Thirty-Day Unplanned Readmission and Its Effect on 90-Day Mortality in Hepatocellular Carcinoma Patients Undergoing Partial Hepatectomy","authors":"Yongyue Qi, T. LeVan, G. Haynatzki, C. Are, P. Farazi","doi":"10.17554/j.issn.2224-3992.2020.09.973","DOIUrl":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.973","url":null,"abstract":"Background : Despite advances of surgical techniques, hepatectomy continues to be potentially dangerous and is associated with postoperative mortality, morbidity and readmission. The objective of this study was to determine the effect of 30-day unplanned readmission on ‘conditional’ 90-day mortality among hepatocellular carcinoma (HCC) patients that underwent partial hepatectomy. Methods : National Cancer Database (NCDB) was queried from 2004 to 2012 for patients with hepatocellular carcinoma (HCC) who underwent partial hepatectomy. Thirty-day unplanned readmission rate, and associated risk factors, was determined for 7,696 patients. The association between 30-day unplanned readmission and conditional 90-day mortality was further addressed. Results : The 30-day unplanned readmission rate for patients with HCC that underwent partial hepatectomy was 5.2%. Risk factors associated with 30-day unplanned readmission were sex, race/ethnicity, Charlson-Deyo score, and annual hospital hepatectomy volume. An overall adjusted odds ratio of having conditional 90-day mortality was 2.325 times higher (95% CI 1.643 - 3.219) among patients with a history of 30-day unplanned readmission than those without. This association was dependent on age, sex, race/ethnicity, insurance status, alpha-fetoprotein (AFP), liver fibrosis, Charlson-Deyo comorbidity score and annual hospital hepatectomy volume. Conclusion : Efforts in patient care should be taken to reduce 30-day unplanned readmission after partial hepatectomy for patients with HCC to reduce conditional 90-day mortality.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"9 1","pages":"3330-3339"},"PeriodicalIF":0.0,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44412342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of gastroenterology and hepatology research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1